South Korea's Economy Minister Pledges Support For Local Biosimilar Companies
This article was originally published in The Pink Sheet Daily
Ministry will invest about $7.5 million by July 2010 in a consortium headed by Samsung Electronics and antibody company ISU Abxis to manufacture nine biosimilar products after their patents expire.
You may also be interested in...
SEOUL - South Korea's Celltrion inked an agreement with U.S.-based Hospira to collaborate on manufacturing and marketing Celltrion's eight biogeneric products in global markets including the U.S. and Europe
South Korea's New Drug Pricing Policy Offers Incentives To Hospitals To Spend Less, Says Health Ministry
SEOUL - South Korea's Ministry for Health, Welfare and Family Affairs plans to unveil on Oct. 31 its new drug reimbursement pricing system, which will lower profits for higher priced generics and still reward hospitals for buying drugs at lower prices
SEOUL - South Korea's FDA is putting the final touches on its EU-modeled initial guidelines for approval and registration of biosimilar products, and anticipates releasing a final version by the end of July